Home › Smoldering Multiple Myeloma › North Carolina
Smoldering Multiple Myeloma clinical trials in North Carolina
4 studies for Smoldering Multiple Myeloma are looking for participants at sites in North Carolina.
Cities in North Carolina
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill
- East Carolina University, Greenville
- University of North Carolina-Hillsborough Campus, Hillsborough
- and 4 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 19, 2026 · NCT03937635CHAAMP (CHArlotte Advocate MGUS Project) Internal Pilot Study
- Atrium Health Levine Cancer, Charlotte
RecruitingObservational studyHealthy volunteers welcome
Ages 30 and older · All sexes · Updated Jul 13, 2026 · NCT06644625Registry for Adults With Plasma Cell Disorders (PCD's)
- North Carolina Cancer Hospital, Chapel Hill
RecruitingObservational study
Ages 18 and older · All sexes · Updated Nov 20, 2025 · NCT03717844Screening for AL Amyloidosis in Smoldering Multiple Myeloma
- Atrium Health Levine Cancer Institute, Charlotte
- UNC Lineberger Comprehensive Cancer Center, Durham
RecruitingObservational study
Ages 40 and older · All sexes · Updated Aug 6, 2025 · NCT06365060From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.